GWS
ITOS

Glassman Wealth Services’s iTeos Therapeutics ITOS Stock Holding History

Glassman Wealth Services’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9
Closed -$176 – 1941
2022
Q4 		$176 Hold
9
– – ﹤0.01% 1823
2022
Q3 		$0 Buy
+9
New +$207 ﹤0.01% 1826
2022
Q2 		– Sell
-24
Closed -$1K – 1836
2022
Q1 		$1K Buy
+24
New +$872 ﹤0.01% 1422

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Glassman Wealth Services's ITOS Position: Q1 2023 in Review

Glassman Wealth Services sold out of iTeos Therapeutics (ITOS) in Q1 2023, closing a stake of 9 shares — an estimated $176 sold.

Glassman Wealth Services first reported a position in ITOS in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 153 funds tracked by Wall St. Rank hold ITOS as of Q1 2023.

  • Glassman Wealth Services reported no remaining iTeos Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 9 iTeos Therapeutics shares in Q1 2023, an estimated $176.
  • Glassman Wealth Services first reported a position in iTeos Therapeutics in Q1 2022 and held it in 3 quarters.
  • Glassman Wealth Services's iTeos Therapeutics position peaked at $1K in Q1 2022.
  • 153 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2023.

Based on Glassman Wealth Services's 13F filing for Q1 2023, filed 4 May 2023.